Combination Therapy of Malignant Glioma Cells With 2-5a-Antisense Telomerase RNA and Recombinant Adenovirus P53

Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3301327
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Combined Effect of 2-5a-Linked Antisense Against Telomerase RNA and Conventional Therapies on Human Malignant Glioma Cells in Vitro and in Vivo

International Journal of Oncology
Cancer ResearchOncology
2007English

Treatment of Prostate Cancer in Vitro and in Vivo With 2-5a-Anti-Telomerase RNA Component(New Era of Antisense Therapy)

Japanese Journal of Urology
Urology
2000English

Combination of Recombinant Adenovirus-P53 With Radiochemotherapy in Unresectable Pancreatic Carcinoma

Chinese Journal of Cancer Research
Cancer ResearchOncology
2011English

Catalytic Cleavage of an RNA Target by 2–5A Antisense and RNase L

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Effective Combination Therapy for Malignant Glioma With TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Cancer Research
Cancer ResearchOncology
2012English

Antisense P53 RNA Abrogates Antisense Rb RNA-Induced Cell Death in Mouse Fibroblast SV-T2 Cells.

Journal of Reproduction and Development
Animal ScienceZoology
1999English

Gene Therapy for Malignant Glioma

Molecular and Cellular Therapies
2014English

Gene Therapy for Malignant Glioma

Japanese Journal of Neurosurgery
SurgeryNeurology
2003English

Oncolytic Viral Therapy of Malignant Glioma

Neurotherapeutics
NeurologyPharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy